Supervised Center-based vs. Unsupervised Home-based Exercise Programs (PRO-Training)
Launched by UNIVERSITY OF CASTILLA-LA MANCHA · Nov 8, 2022
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called PRO-Training, is looking at different types of exercise programs to see which is best for improving physical and mental health in older adults aged 60 to 75. The researchers want to find out if exercising in a supervised center is better than exercising at home on your own, and if having motivation helps people stick with their exercise routines. A total of 120 participants will be randomly assigned to one of five groups: one will not exercise at all, while the others will follow either a supervised or unsupervised exercise program, some with motivational support and some without. The exercise program will last for 24 weeks, with sessions three times a week.
To be eligible for this study, participants must be between 60 and 75 years old, able to walk independently, and able to read and speak Spanish. They should also have a smartphone and be comfortable using apps. However, those with certain medical conditions, such as severe heart issues, uncontrolled diabetes, or significant neurological diseases, will not be able to participate. Throughout the trial, participants will undergo various health assessments to measure improvements in their strength, physical fitness, mental well-being, and overall quality of life. This study aims to provide valuable insights into how different exercise approaches can benefit older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People aged between 60 and 75 years old.
- • Being able to speak and read fluent Spanish.
- • Being able to walk independently.
- • Being physically able to participate in an exercise program.
- • Having a smartphone and being able to understand and use mobile applications autonomously.
- Exclusion Criteria:
- • Acute or terminal illness.
- • Myocardial infarction, coronary artery bypass grafting, angioplasty, angina, or other cardiac condition in the past year.
- • Uncontrolled medical problems that the general practitioner considers would preclude patients from undertaking the exercise program (e.g., acute systemic illness such as pneumonia, acute rheumatoid arthritis, and acute or unstable heart failure).
- • Conditions requiring a specialized physical exercise program (e.g., uncontrolled epilepsy, significant neurological disease or impairment, inability to maintain an upright seated position or unable to move independently, multiple sclerosis, cancer, Parkinson's, Alzheimer's, or chronic obstructive pulmonary disease).
- • General practitioner-diagnosed hypertension that has not been controlled.
- • Type I Diabetes or uncontrolled Type II Diabetes.
- • History of major psychiatric illness including schizophrenia, generalized anxiety disorder, or depression according to the DSM-5.
- • Morbid obesity (body mass index \>39)
- • Three or more self-reported falls in the last year.
- • Not living in the community (e.g., living in nursing homes).
- • Having participated in an exercise program during the 6 months prior to the study.
- • Diagnosis of COVID-19 with hospitalization in intensive care unit.
- • Any other consideration that interferes with the study aims and could be a risk to the participant, at the discretion of the researcher and the general practitioner.
About University Of Castilla La Mancha
The University of Castilla-La Mancha is a prominent academic institution dedicated to advancing research and innovation in various fields, including health sciences. With a commitment to fostering interdisciplinary collaboration, the university engages in groundbreaking clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Its research initiatives are supported by a robust network of experts and cutting-edge facilities, positioning the university as a leading sponsor in clinical research within the region. Through its rigorous ethical standards and dedication to scientific excellence, the University of Castilla-La Mancha strives to contribute significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toledo, Castilla La Mancha/Toledo, Spain
Toledo, , Spain
Patients applied
Trial Officials
Asier Mañas, Ph.D.
Principal Investigator
GENUD Toledo Research Group, University of Castilla-La Mancha
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials